Ontology highlight
ABSTRACT: Background
Osteoarthritis (OA) is a chronic disease that attacks joints and bones which can be caused by trauma or other joint diseases. Stem cell and Conditioned Medium (CM) of stem cells are developed for OA therapy, which is minimally invasive. It can decrease inflammation and be a replacement for knee surgery. This study aimed to utilize human Wharton's Jelly-Mesenchymal Stem Cells (hWJMSCs) as an alternative OA therapy.Methods
CM from hWJMSCs induced by IGF1 was collected. The OA cells model (IL1β-CHON002) culture was treated as follows: 1) with hWJMSCs-CM 15% (v/v); 2) with hWJMSCs-CM 30% (v/v); 3) with IGF1-hWJMSCs (IGF1-hWJMSCs-CM) 15% (v/v); 4) with IGF1-hWJMSCs-CM 30% (v/v). Parameters including inflammatory cytokines (IL10 and TNFα), extracellular matrix degradation (MMP3 expression), and chondrogenic marker (COL2 expression) were determined.Results
The most significant increase in COL2 chondrogenic markers was found in IL1β-CHON002 treatment using 15% CM of hWJMSCs induced with IGF1. CM of hWJMSCs can reduce inflammatory cytokines (TNFα and IL10) and matrix degradation mediator MMP3. Better result was gained from IGF1-induced hWJMSCs-CM.Conclusion
CM of IGF1-hWJMSCs reduce inflammation while repairing injured joint in the human chondrocyte OA model.
SUBMITTER: Kusuma HSW
PROVIDER: S-EPMC7368112 | biostudies-literature | 2020 Jul-Sep
REPOSITORIES: biostudies-literature
Kusuma Hanna Sari Widya HSW Widowati Wahyu W Gunanegara Rimonta Febby RF Juliandi Berry B Lister Nyoman Ehrich NE Arumwardana Seila S Yusepany Dewani Tediana DT Artie Dwi Surya DS Nataya Enden Dea ED Gunawan Kamila Yashfa KY Sholihah Ika Adhani IA Girsang Ermi E Ginting Chrismis Novalinda CN Bachtiar Indra I Murti Harry H
Avicenna journal of medical biotechnology 20200701 3
<h4>Background</h4>Osteoarthritis (OA) is a chronic disease that attacks joints and bones which can be caused by trauma or other joint diseases. Stem cell and Conditioned Medium (CM) of stem cells are developed for OA therapy, which is minimally invasive. It can decrease inflammation and be a replacement for knee surgery. This study aimed to utilize human Wharton's Jelly-Mesenchymal Stem Cells (hWJMSCs) as an alternative OA therapy.<h4>Methods</h4>CM from hWJMSCs induced by IGF1 was collected. T ...[more]